NCT07039019View on ClinicalTrials.gov

Study of the Feasibility and Efficacy of PrednisonE for Non-specifiC pleuriTis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 4, 2025

Primary Completion Date

November 19, 2026

Study Completion Date

November 19, 2026

Conditions
Pleuritis, Non-specific
Interventions
DRUG

Corticosteroid

Patients take 40 mg of prednisone daily for 4 weeks to help reduce inflammation.

OTHER

No Corticosteroid

Patients do not take corticosteroid.

Trial Locations (2)

10029

RECRUITING

Mount Sinai Hospital, New York

RECRUITING

Mount Sinai Morningside, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER